Pharmsville Co., Ltd. Logo

Pharmsville Co., Ltd.

Develops and distributes health supplements and microbiome probiotics globally.

318010 | KO

Overview

Corporate Details

ISIN(s):
KR7318010006
LEI:
Country:
South Korea
Address:
서울특별시 강서구 마곡중앙8로3길 37 -, 강서구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Pharmsville Co., Ltd. is a bio-healthcare company founded in 2000 that specializes in the research, development, production, and distribution of health functional foods and nutritional supplements. The company focuses on creating innovative products, with a particular specialization in microbiome-based probiotics designed to support human wellness. Its product portfolio includes a range of dietary supplements for functions such as energy metabolism and weight management. Operating its own bio-lab, Pharmsville is dedicated to the research and development of new materials for its health products. The company serves its domestic market and exports to a global network of countries across Asia, Europe, and North America.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.2 MB
2025-05-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.0 KB
2025-05-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 39.9 KB
2025-05-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 110.3 KB
2025-04-02 00:00
Director's Dealing
임원ㆍ주요주주특정증권등거래계획보고서
Korean 41.0 KB
2025-04-02 00:00
Director's Dealing
임원ㆍ주요주주특정증권등거래계획보고서
Korean 49.4 KB
2025-03-28 00:00
AGM Information
정기주주총회결과
Korean 26.8 KB
2025-03-28 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 12.0 KB
2025-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 25.7 KB
2025-03-19 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.6 MB
2025-03-13 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 8.5 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 165.7 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 15.2 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 4.6 KB

Automate Your Workflow. Get a real-time feed of all Pharmsville Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pharmsville Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pharmsville Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Annexon, Inc. Logo
Developing C1q inhibitors for autoimmune, neurodegenerative, and ophthalmic diseases.
United States of America
ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
South Korea
065660
Antibiotice S.A. Logo
Develops and manufactures generic medicines and APIs, specializing in anti-infectives.
Romania
ATB
Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America
APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America
APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany
APPH
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America
APLT
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea
003060

Talk to a Data Expert

Have a question? We'll get back to you promptly.